Fund profile · Compiled from public sources

Invivo Partners

Pre-seed → Series A

Their stated focus (public profile)

Invivo Partners is a European venture capital firm specializing in early-stage biotechnology and AI/deeptech companies. In biotech, they focus on companies with strong in vivo proof of concept developing innovative drugs, with particular interest in advanced therapies and synthetic biology. In deeptech, they back AI-driven companies addressing real-world problems primarily in healthcare, as well as robotics, aerospace, mobility, computing, and climate. They focus on European companies with a special emphasis on Spanish opportunities.

Stages: Pre-seed → Series A

Sectors: Life sciences, Healthtech, AI / ML, Deep tech, Robotics, Space tech, Mobility & transportation, Computing, Climate tech

Check size: Initial investments range from 2-4M€, with follow-ons in portfolio companies up to 10M€ per company after meeting set milestones

On file: 3 partners on record · 7 companies on record

Website: invivo.partners

This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.

Is this your fund? Request a correction or removal.

For founders · Find a fund

Search the funds we have on file

Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.

    Looking to claim your own fund? Start here →